Bottom line
FRBRX vs BBH: the short answer
FRBRX (Franklin Biotechnology Discovery Fund) and BBH (VanEck Biotech ETF) are both mutual funds.
But FRBRX is far broader, holding 126 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
BBH is cheaper at 0.35% vs 0.67% — a difference of $32 a year per $10,000 invested.
Over five years, FRBRX returned +6.6% a year vs +2.7% for BBH.
Updated Nov 19, 2026
FRBRX vs BBH side by side
| FRBRX | BBH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Franklin Templeton | VanEck |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.67% | 0.35% |
| Annual cost per $10k | $67 | $35 |
| 10-yr cost on $10k (prospectus) | $955 | $443 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +52.8% | +21.2% |
| 5-yr return (annualized) | +6.6% | +2.7% |
| 10-yr return (annualized) | +7.4% | +4.5% |
| Best quarter | — | +27.6% |
| Worst quarter | — | −18.2% |
| Net assets (fund) | $1.2B | $395.6M |
| Number of holdings | 126 | 25 |
| Portfolio turnover | 38% | 19% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
8 of FRBRX's top 25 holdings also appear in BBH's top 25.
| Holding | FRBRX | BBH |
|---|---|---|
| Amgen, Inc. | 4.39% | 15.25% |
| Gilead Sciences, Inc. | 3.86% | 12.79% |
| Regeneron Pharmaceuticals, Inc. | 3.77% | 6.21% |
| Argenx SE | 3.62% | 4.97% |
| Vertex Pharmaceuticals, Inc. | 3.54% | 9.10% |
| Revolution Medicines, Inc. | 3.01% | 5.27% |
| Insmed, Inc. | 1.99% | 2.67% |
| Neurocrine Biosciences, Inc. | 1.82% | 2.08% |
Source: SEC Form N-PORT
FRBRX top 10
- Jazz Pharmaceuticals plc — 5.66%
- Amgen, Inc. — 4.39%
- Gilead Sciences, Inc. — 3.86%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Argenx SE — 3.62%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
BBH top 10
- Amgen Inc — 15.25%
- Gilead Sciences Inc — 12.79%
- Vertex Pharmaceuticals Inc — 9.10%
- Regeneron Pharmaceuticals Inc — 6.21%
- Revolution Medicines Inc — 5.27%
- Argenx SE — 4.97%
- Natera Inc — 4.92%
- IQVIA Holdings Inc — 4.31%
- Alnylam Pharmaceuticals Inc — 3.83%
- Biogen Inc — 3.63%
FAQ
What is the difference between FRBRX and BBH?
Which is cheaper, FRBRX or BBH?
Should I own both FRBRX and BBH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.